Skip to main content

CG Oncology, Inc.

CGON
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001991792

In the last 90 days, CG Oncology, Inc. insiders filed 0 open-market purchases and 4 sales; 227 institutions reported holding it in 13F filings for Q2 2026, worth $6.66B in total; no superinvestor holds it.

13F holders, Q2 2025

Institutional positions in CG Oncology, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
163
+22 vs. Q1 2025
Shares held
75.9M
+5.15M (+7.3%) vs. Q1 2025
Total value
$1.97B
+$238.1M (+13.7%) vs. Q1 2025
New holders
41
77 more added
Sold out
19
28 more reduced

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CGON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2025: 163 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 96 institutionsQ2 2024: 111 institutionsQ3 2024: 121 institutionsQ4 2024: 140 institutionsQ1 2025: 142 institutionsQ2 2025: 163 institutionsQ3 2025: 176 institutionsQ4 2025: 195 institutionsQ1 2026: 233 institutionsQ2 2026: 227 institutions
Value heldQ2 2025: $1.97B
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $1.70BQ2 2024: $1.37BQ3 2024: $1.96BQ4 2024: $1.90BQ1 2025: $1.74BQ2 2025: $1.97BQ3 2025: $3.13BQ4 2025: $3.43BQ1 2026: $6.03BQ2 2026: $6.66B
Institutions holding CGON and their total value by quarter
QuarterHoldersValue
Q2 2026227$6.66B
Q1 2026233$6.03B
Q4 2025195$3.43B
Q3 2025176$3.13B
Q2 2025163$1.97B
Q1 2025142$1.74B
Q4 2024140$1.90B
Q3 2024121$1.96B
Q2 2024111$1.37B
Q1 202496$1.70B
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2025

Shares, value and share of portfolio for each institution holding CG Oncology, Inc.; share changes are against Q1 2025.

Institutions holding CGON in Q2 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Rhumbline Advisers82,424$2.14M0.00%+7,735+10.4%Added
Cinctive Capital Management LP84,856$2.21M0.12%+65,901+347.7%Added
Canada Pension Plan Investment Board86,600$2.25M0.00%+86,600New
Tang Capital Management LLC87,500$2.27M0.11%+87,500New
Susquehanna International Group, LLP93,793$2.44M0.00%+11,808+14.4%Added
Ameriprise Financial Inc110,456$2.87M0.00%+91,211+473.9%Added
AQR Capital Management LLC113,032$2.94M0.00%+93,651+483.2%Added
Nuveen, LLC138,782$3.61M0.00%−27,992−16.8%Reduced
Bank of New York Mellon Corp146,663$3.81M0.00%−897−0.6%Reduced
Alyeska Investment Group, L.P.150,000$3.90M0.01%+150,000New
Manufacturers Life Insurance Company, The153,872$4.00M0.00%+76,437+98.7%Added
Soleus Capital Management, L.P.155,000$4.03M0.28%−148,585−48.9%Reduced
Ikarian Capital, LLC155,000$4.03M1.33%+155,000New
Citadel Advisors LLC175,253$4.56M0.00%−963,665−84.6%Reduced
Rosalind Advisors, Inc.192,974$5.02M2.43%+192,974New
TD Asset Management Inc203,872$5.30M0.00%+135,566+198.5%Added
Massachusetts Financial Services Co249,664$6.49M0.00%−8,426−3.3%Reduced
Dimensional Fund Advisors LP259,211$6.74M0.00%+227,053+706.1%Added
CenterBook Partners LP260,099$6.76M0.38%+56,971+28.0%Added
Schroder Investment Management Group264,039$6.87M0.01%+155,737+143.8%Added
Opaleye Management Inc.266,000$6.92M1.40%+102,012+62.2%Added
ArrowMark Colorado Holdings LLC293,006$7.62M0.14%+57,812+24.6%Added
Barclays PLC346,500$9.01M0.00%+253,961+274.4%Added
Ensign Peak Advisors, Inc396,479$10.3M0.02%+262,079+195.0%Added
Charles Schwab Investment Management Inc450,296$11.7M0.00%+11,018+2.5%Added
Northern Trust Corp468,102$12.2M0.00%−3,662−0.8%Reduced
TimesSquare Capital Management, LLC512,201$13.3M0.19%−5,057−1.0%Reduced
ADAR1 Capital Management, LLC523,216$13.6M2.21%+222,082+73.7%Added
Silverarc Capital Management, LLC541,034$14.1M2.88%+541,034New
Mangrove Partners555,117$14.4M1.55%+555,117New
Saturn V Capital Management LLC586,647$15.3M6.18%+8,951+1.5%Added
Cormorant Asset Management, LP625,000$16.3M1.21%−150,000−19.4%Reduced
Woodline Partners LP629,357$16.4M0.09%−135,000−17.7%Reduced
Candriam Luxembourg S.C.A.763,580$19.9M0.11%+763,580New
Frazier Life Sciences Management, L.P.770,000$20.0M0.80%00.0%Unchanged
UBS Asset Management Americas Inc856,597$22.3M0.00%+677,234+377.6%Added
Millennium Management LLC959,968$25.0M0.02%+363,912+61.1%Added
Foresite Capital Management V, LLC1,004,050$26.1M32.34%+145,000+16.9%Added
Polar Capital Holdings Plc1,098,662$28.6M0.15%+55,802+5.4%Added
Acorn Capital Advisors, LLC1,131,501$29.4M19.24%00.0%Unchanged
Goldman Sachs Group Inc1,187,101$30.9M0.00%+419,835+54.7%Added
Geode Capital Management, LLC1,335,437$34.7M0.00%+56,203+4.4%Added
Pictet Asset Management Holding SA1,354,383$35.2M0.04%+606,554+81.1%Added
Point72 Asset Management, L.P.1,475,293$38.4M0.09%−191,881−11.5%Reduced
Franklin Resources Inc1,486,839$38.7M0.01%+167,905+12.7%Added
Avidity Partners Management LP1,499,942$39.0M7.82%+519,000+52.9%Added
RTW Investments, LP1,701,216$44.2M0.63%00.0%Unchanged
Bank of America Corp1,736,769$45.2M0.00%+1,396,170+409.9%Added
Morgan Stanley1,868,148$48.6M0.00%+923,067+97.7%Added
OrbiMed Advisors LLC1,877,850$48.8M1.23%−594,144−24.0%Reduced
Wellington Management Group LLP1,898,894$49.4M0.01%−226,314−10.6%Reduced
Price T Rowe Associates Inc2,013,690$52.4M0.01%+999,094+98.5%Added
Alliancebernstein L.P.2,164,214$56.3M0.02%+281,637+15.0%Added
State Street Corp2,165,753$56.3M0.00%+198,264+10.1%Added
Foresite Capital Management VI LLC2,221,474$57.8M32.47%00.0%Unchanged
UBS Group AG2,229,245$58.0M0.01%+524,527+30.8%Added
Kynam Capital Management, LP2,457,667$63.9M6.88%−153,995−5.9%Reduced
Braidwell LP3,283,317$85.4M2.92%00.0%Unchanged
TCG Crossover Management, LLC3,670,206$95.4M10.90%00.0%Unchanged
FMR LLC3,856,261$100.3M0.01%+1,311,163+51.5%Added
BlackRock, Inc.4,456,423$115.9M0.00%+101,363+2.3%Added
Vanguard Group Inc5,906,511$153.6M0.00%+70,191+1.2%Added
Decheng Capital LLC6,371,669$165.7M41.84%00.0%Unchanged
Marshall Wace, LLP0$00.00%−2,418,456−100.0%Sold out
Deerfield Management Company, L.P. (Series C)0$00.00%−850,695−100.0%Sold out
ABG-WTT Global Life Science Capital Partners GP Ltd0$00.00%−495,526−100.0%Sold out
StemPoint Capital LP0$00.00%−289,823−100.0%Sold out
Fan Yu0$00.00%−163,456−100.0%Sold out
Ally Bridge Group (NY) LLC0$00.00%−132,298−100.0%Sold out
Susquehanna Fundamental Investments, LLC0$00.00%−89,833−100.0%Sold out
Walleye Capital LLC0$00.00%−82,265−100.0%Sold out
Jain Global LLC0$00.00%−54,050−100.0%Sold out
Verition Fund Management LLC0$00.00%−44,051−100.0%Sold out
Corebridge Financial, Inc.0$00.00%−26,514−100.0%Sold out
Fox Run Management, L.L.C.0$00.00%−16,676−100.0%Sold out
CIBC World Markets Corp0$00.00%−12,009−100.0%Sold out
Aster Capital Management (DIFC) Ltd0$00.00%−192−100.0%Sold out
Clear Street Markets LLC0$00.00%−163−100.0%Sold out
Coldstream Capital Management Inc0$00.00%−58−100.0%Sold out
Signaturefd, LLC0$00.00%−42−100.0%Sold out
Stephens Consulting, LLC0$00.00%−15−100.0%Sold out
AdvisorNet Financial, Inc0$00.00%−2−100.0%Sold out
Lindbrook Capital, LLC––––Not filed